Sakar Healthcare Limited — Board Meeting, 15-05-2025: Outcome of Board Meeting

Sakar Healthcare has announced a board meeting on which it approved the audited consolidated financial results for FY25. Total income rose to ₹178.90 Cr from ₹156.53 Cr, while profit before tax jumped to ₹21.53 Cr versus ₹15.90 Cr last year. Net profit surged to ₹17.50 Cr, translating to an EPS of ₹7.97. Despite increased employee costs and depreciation, operating expenses remained under control. The company’s strong balance sheet shows equity at ₹285.48 Cr with stable borrowings. Recent funds raised were fully deployed toward debt repayment, oncology unit expansion, and corporate expenses.